MRNS
Marinus Pharmaceuticals Inc
$6.73
Earnings Summary
Revenue | $7.34Mn |
Net Profits | $-32.97Mn |
Net Profit Margins | -449.33% |
Highlights
Marinus Pharmaceuticals Inc’s revenue jumped 213.59% since last year same period to $7.34Mn in the Q3 2023. On a quarterly growth basis, Marinus Pharmaceuticals Inc has generated 20.67% jump in its revenue since last 3-months.
Marinus Pharmaceuticals Inc’s net profit fell -144.99% since last year same period to $-32.97Mn in the Q3 2023. On a quarterly growth basis, Marinus Pharmaceuticals Inc has generated -3.25% fall in its net profits since last 3-months.
Marinus Pharmaceuticals Inc’s net profit margin fell -114.35% since last year same period to -449.33% in the Q3 2023. On a quarterly growth basis, Marinus Pharmaceuticals Inc has generated 14.44% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Marinus Pharmaceuticals Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.63 |
EPS Estimate Current Year | -0.63 |
Highlights
Marinus Pharmaceuticals Inc’s earning per share (EPS) estimates for the current quarter stand at -0.63 - a 4.55% jump from last quarter’s estimates.
Marinus Pharmaceuticals Inc’s earning per share (EPS) estimates for the current year stand at -0.63.
Key Ratios
Key ratios of the Marinus Pharmaceuticals Inc post its Q3 2023 earnings
Earning Per Share (EPS) | -0.61 |
Highlights
Marinus Pharmaceuticals Inc’s earning per share (EPS) jumped 35.11% since last year same period to -0.61 in the Q3 2023. This indicates that the Marinus Pharmaceuticals Inc has generated 35.11% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-07 | -0.66 | -0.61 | 7.58% |
2023-05-11 | -0.72 | -0.67 | 6.94% |
2023-08-10 | -0.72 | -0.61 | 15.28% |
₹0 US Stocks a/c Opening Fee